Phospho-p38 MAPK (Thr180/Tyr182) AntibodyProduct information
Product Pathways - MAPK Signaling
Phospho-p38 MAPK (Thr180/Tyr182) Antibody #9211
|9211L||600 µl (60 western blots)||---||In Stock||---|
|9211S||200 µl (20 western blots)||---||In Stock||---|
|9211||carrier free and custom formulation / quantity||email request|
|W||1:1000||Human, Mouse, Rat, Monkey, D. melanogaster, Pig, S. cerevisiae||Endogenous||43||Rabbit|
Species cross-reactivity is determined by western blot.
Applications Key: W=Western Blotting, IP=Immunoprecipitation, IF-IC=Immunofluorescence (Immunocytochemistry), F=Flow Cytometry
Species predicted to react based on 100% sequence homology: Hamster, Zebrafish, Bovine.
Specificity / Sensitivity
Phospho-p38 MAPK (Thr180/Tyr182) Antibody detects endogenous levels of p38 MAPK only when activated by phosphorylation at threonine 180 and tyrosine 182. This antibody does not cross-react with the phosphorylated forms of either p42/44 MAPK or SAPK/JNK. It will also react with p38 singly phosphorylated at Thr180 and singly phosphorylated at Tyr182.
Source / Purification
Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues around Thr180/Tyr182 of human p38 MAPK. Antibodies are purified by protein A and peptide affinity chromatography.
Western blot analysis of extracts from C6 cells, untreated or anisomycin-treated, and NIH/3T3 cells, untreated or UV-treated, using Phospho-p38 MAPK (Thr180/Tyr182) Antibody (upper) or p38 MAPK Antibody #9212 (lower).
Western blot analysis of extracts from UV-treated NIH/3T3 cells, using Phospho-p38 MAPK (Thr180/Tyr182) Antibody (upper) or control p38 MAPK Antibody #9212 (lower).
Confocal immunofluorescent analysis of HeLa cells -/+ UV light, labeled with Phospho-p38 MAPK (green). Absence of staining in untreated cells (left) and nuclear localization in treated cells (right). Red = Actin filaments (phalloidin).
p38 MAP kinase (MAPK), also called RK (1) or CSBP (2), is the mammalian orthologue of the yeast HOG kinase that participates in a signaling cascade controlling cellular responses to cytokines and stress (1-4). Four isoforms of p38 MAPK, p38α, β, γ (also known as Erk6 or SAPK3), and δ (also known as SAPK4) have been identified. Similar to the SAPK/JNK pathway, p38 MAPK is activated by a variety of cellular stresses including osmotic shock, inflammatory cytokines, lipopolysaccharide (LPS), UV light, and growth factors (1-5). MKK3, MKK6, and SEK activate p38 MAPK by phosphorylation at Thr180 and Tyr182. Activated p38 MAPK has been shown to phosphorylate and activate MAPKAP kinase 2 (3) and to phosphorylate the transcription factors ATF-2 (5), Max (6), and MEF2 (5-8). SB203580 (4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-imidazole) is a selective inhibitor of p38 MAPK. This compound inhibits the activation of MAPKAPK-2 by p38 MAPK and subsequent phosphorylation of HSP27 (9). SB203580 inhibits p38 MAPK catalytic activity by binding to the ATP-binding pocket, but does not inhibit phosphorylation of p38 MAPK by upstream kinases (10).
- Rouse, J. et al. (1994) Cell 78, 1027-37.
- Han, J. et al. (1994) Science 265, 808-11.
- Lee, J.C. et al. (1994) Nature 372, 739-46.
- Freshney, N.W. et al. (1994) Cell 78, 1039-49.
- Raingeaud, J. et al. (1995) J Biol Chem 270, 7420-6.
- Zervos, A.S. et al. (1995) Proc Natl Acad Sci U S A 92, 10531-4.
- Zhao, M. et al. (1999) Mol Cell Biol 19, 21-30.
- Yang, S.H. et al. (1999) Mol Cell Biol 19, 4028-38.
- Cuenda, A. et al. (1995) FEBS Lett 364, 229-33.
- Kumar, S. et al. (1999) Biochem Biophys Res Commun 263, 825-31.
- Yang, P. et al. (2010) Nat Immunol 11, 487-94. Applications: Western Blotting.
- Kawagoe, T. et al. (2008) Nat Immunol 9, 684-91. Applications: Western Blotting.
- Herczenik, E. et al. (2007) Arterioscler Thromb Vasc Biol 27, 1657-65. Applications: Western Blotting.
- Zaru, R. et al. (2007) Nat Immunol 8, 1227-35. Applications: Western Blotting.
- Hsu, J.T. et al. (2007) Am J Physiol Heart Circ Physiol 292, H2982-7. Applications: Western Blotting.
- Goss, V.L. et al. (2006) Blood 107, 4888-97. Applications: Western Blotting.
- Matsumoto, M. et al. (2004) J Biol Chem 279, 45969-79. Applications: IF-IC (In Cells).
- Patrucco, E. et al. (2004) Cell 118, 375-387. Applications: Western Blotting.
- Hata, K. et al. (2003) Mol. Biol. Cell 14, 545-555. Applications: Western Blotting.
- Liu, F. et al. (2002) Mol Endocrinol 16, 419-34. Applications: Western Blotting.
- Xing, H. et al. (2000) . EMBO J. 19, 349-358. Applications: Western Blotting.
- Villunger, A. et al. (2000) . J. Exp. Med. 192, 647-658. Applications: Western Blotting.
- Lee, Y. W. et al. (2000) . Cancer Lett. 156, 133-139. Applications: Western Blotting.
- Uddin, S. et al. (2000) . J. Biol. Chem. 275, 27634-27640. Applications: Western Blotting.
- Gonda, R.L. et al. (2012) PLoS One 7, e42369. Applications: Western Blotting.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 2222 Anisomycin
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 4631 Phospho-p38 MAPK (Thr180/Tyr182) (12F8) Rabbit mAb
- 9216 Phospho-p38 MAPK (Thr180/Tyr182) (28B10) Mouse mAb
- 9219 Phospho-p38 MAPK (Thr180/Tyr182) (28B10) Mouse mAb (Sepharose® Bead Conjugate)
- 9215 Phospho-p38 MAPK (Thr180/Tyr182) (3D7) Rabbit mAb
- 4511 Phospho-p38 MAPK (Thr180/Tyr182) (D3F9) XP® Rabbit mAb
- 9913 Phospho-p38 MAPK Pathway Sampler Kit
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
- 9212 p38 MAPK Antibody
- 9213 p38 MAPK Control Cell Extracts
- 9217 p38α MAPK (5F11) Mouse mAb
- 2371 p38α MAPK (7D6) Rabbit mAb
- 9228 p38α MAPK (L53F8) Mouse mAb
- 9218 p38α MAPK Antibody
- 2339 p38β MAPK (C28C2) Rabbit mAb
- 2307 p38γ MAPK Antibody
- 2308 p38δ MAPK (10A8) Rabbit mAb
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.